JPMorgan analyst Andrea Teixeira lowered the firm’s price target on Procter & Gamble to $181 from $186 and keeps an Overweight rating on the shares. The firm anticipates an “eventful earnings season” for the household and personal care group, with key debates into 2025 of consumption behavior, impact of currency, tariff risk for multinationals, financial expenses on higher rates for longer, and asset allocation. In light of the new U.S. administration and “many puts and takes” from a macro-political standpoint, JPMorgan expects companies will opt for a “very conservative approach to their outlook.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble Restructures to Enhance Global Efficiency
- After a Disappointing Year, Adobe Could Be Due for a Recovery
- The Dow Jones is Still Dropping After the December Fed Meeting
- Procter & Gamble price target raised to $192 from $181 at Deutsche Bank
- UnitedHealth (UNH) Hits Dow Jones Hard after CEO’s Assassination